The global medical industry experienced a 25% decline in the number of artificial intelligence-related patent applications in Q3 2023 compared with the previous quarter. The total number of artificial intelligence-related grants dropped by 22% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of artificial intelligence-related patent applications in the medical industry was 2,335 in Q3 2023, versus 3,125 in the prior quarter.
The top five companies accounted for 11% of patenting activity
Analysis of patenting activity by companies shows that Siemens filed the most artificial intelligence patents within the medical industry in Q3 2023. The company filed 72 artificial intelligence-related patents in the quarter, compared with 50 in the previous quarter. It was followed by Koninklijke Philips with 72 artificial intelligence patent filings, Fujifilm (50 filings), and Medtronic (39 filings) in Q3 2023.
Patenting activity was driven by the US with a 42% share of total patent filings
The largest share of artificial intelligence related patent filings in the medical industry in Q3 2023 was in the US with 42%, followed by China (16%) and South Korea (7%). The share represented by the US was 5% higher than the 37% share it accounted for in Q2 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2023, buy the databook here.